Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.

AIDS (London, England) - 28 Sept 2001

Gallego O, Ruiz L, Vallejo A, Ferrer E, Rubio A, Clotet B, Leal M, Soriano V

Abstract excerpt

Genotypic resistance to antiretroviral drugs was examined in 684 individuals attending 18 outpatient clinics distributed across Spain in June 2000. Compared with similar surveys conducted before 1998, the prevalence of resistance to nucleosides has declined significantly among naive chronic HIV carriers. In contrast, resistance among pre-treated patients has increased; resistance to all three drug families having...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Multiple, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Protease

Share to HIV Protease Inhibitors

Share to HIV Reverse Transcriptase

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 11579258
DOI: 10.1097/00002030-200109280-00025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.PMID 11579258Read ↗

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid.Semantic proximity Read ↗

Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.Semantic proximity Read ↗

Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.Semantic proximity Read ↗

[Epidemiology of drug-resistant HIV-1 transmission in naïve patients in Spain].Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group.Semantic proximity Read ↗

Analysis of transmitted drug resistance in Spain in the years 2007-2010 documents a decline in mutations to the non-nucleoside drug class.Semantic proximity Read ↗

Rate of virological treatment failure and frequencies of drug resistance genotypes among human immunodeficiency virus-positive subjects on antiretroviral therapy in Spain.Semantic proximity Read ↗

Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.Semantic proximity Read ↗

Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade.Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in SpainSemantic proximity Read ↗

Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients.Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.